Table 1. Drugs from the FDA Table of Pharmacogenomic Biomarkers in Drug Labeling included in literature review.
Therapeutic area | Count | Drugs |
---|---|---|
Oncology | 11 | Capecitabine, cisplatin, dabrafenib, fluorouracil, irinotecan, lapatinib, mercaptopurine, nilotinib, pazopanib, rasburicase, thioguanine |
Infectious diseases | 10 | Abacavir, chloroquine, dapsone, mafenide, nalidixic acid, nitrofurantoin, primaquine, quinine sulphate, rifampin+isoniazid+pyrazinamidea, sulfamethoxazole+trimethoprima |
Psychiatry | 9 | Aripiprazole, atomoxetine, citalopram, clozapine, fluvoxamine, iloperidone, perphenazine, pimozide, thioridazine |
Neurology | 8 | Carbamazepine, clobazam, dextromethorphan+quinidinea, divalproex, phenytoin, tetrabenazine, valproic acid, vortioxetine |
Cardiology | 5 | Carvedilol, clopidogrel, isosorbide+hydralazinea, metoprolol, propafenone |
Gastroenterology | 5 | Dexlansoprazole, esomeprazole, metoclopramide, PEG-3350+sodium sulphate+sodium chloride+potassium chloride+sodium ascorbate+ascorbic acida, rabeprazole |
Rheumatology | 5 | Azathioprine, carisoprodol, celecoxib, flurbiprofen, pegloticase |
Endocrinology | 4 | Chlorpropamide, glimepiride, glipizide, glyburide |
Haematology | 3 | Eltrombopag, methylene blue, warfarin |
Analgesic | 1 | Tramadol |
Anaesthesiology | 1 | Codeine |
Dental | 1 | Cevimeline |
Genitourinary | 1 | Tolterodine |
Inborn errors of metabolism | 1 | Eliglustat |
Pulmonary | 1 | Ivacaftor |
Toxicology | 1 | Sodium nitrite |
Transplantation | 1 | Mycophenolic acid |
Abbreviation: FDA, Food and Drug Administration.
Drugs in bold had economic evaluations available.
Multiple drugs on a single FDA label.